Key result
Intravascular molecular and hybrid imaging aids detection of high-risk atherosclerotic plaques and patients.
Answers are grounded in this paper and cite their sources.
Reviews intravascular molecular imaging approaches for plaque biology in coronary disease, highlighting hybrid modalities to identify high-risk cardiovascular lesions.
Progression of atherosclerotic plaque in coronary arteries is characterized by complex cellular and non-cellular molecular interactions. Within recent years, atherosclerosis has been recognized as inflammation-driven disease condition, where progressive stages are characterized by morphological changes in plaque composition but also relevant molecular processes resulting in increased plaque vulnerability. While existing intravascular imaging modalities are able to resolve key morphological features during plaque progression, they lack capability to characterize the molecular profile of advanced atherosclerotic plaque. Because hybrid imaging modalities may provide incremental information related to plaque biology, they are expected to provide synergistic effects in detecting high risk patients and lesions. The aim of this article is to review existing literature on intravascular molecular imaging approaches, and to provide clinically oriented proposals of their application. In addition, we assembled an overview of future developments in this field geared towards detection of patients at risk for cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Seguchi et al. (2022) conducted a review in Atherosclerosis. Intravascular molecular imaging vs. Existing intravascular imaging modalities was evaluated. Intravascular molecular and hybrid imaging modalities may provide incremental biological information to detect high-risk atherosclerotic plaques and patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: